Advertisement

Topics

ChromaDex Corporation Reports First Quarter 2019 Financial Results

11:01 EDT 9 May 2019 | BioMedReports - Blog

- First Quarter 2019 Net Revenues Increased by 53% to $10.0 Million -

First Quarter 2019 Highlights vs. First Quarter 2018

  • Strong start to the year with $10.0 million of net sales, higher gross margins and increased marketing efficiency
  • Continued progress building TRU NIAGEN into a global brand with top-line momentum
  • TRU NIAGEN net sales were $7.5 million, a 15% increase sequentially and a 146% increase year-over-year
  • Global expansion continued with e-Commerce roll-out in Canada.  Set foundation for initial Canadian retail launch with Showcase and WELL Health Technologies in April

LOS ANGELES, May 09, 2019 (GLOBE NEWSWIRE)

Read more...

Original Article: ChromaDex Corporation Reports First Quarter 2019 Financial Results

NEXT ARTICLE

More From BioPortfolio on "ChromaDex Corporation Reports First Quarter 2019 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...